2013 US Clinical Chemistry And Immunodiagnostics Markets
PSA Tests
Major Companies Developing or Marketing
Vitamin B-12/Folate Tests
Major Companies Developing or Marketing
CRP Tests Major Companies Developing or Marketing Drugs of Abuse Tests Major Companies Developing or Marketing Biosensors for Immunological Testing Executive Summary Table: U.S.A., Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category U.S.A., Laboratories Performing Chemistry and Immunoassay Testing By Market Segment U.S.A., Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size U.S.A., Commercial/Private Laboratories Performing Chemistry and Immunoassay Tests By Annual Test Volume U.S.A., Total Chemistry and Immunoassay Specimen Volume Forecast U.S.A., All Market Segments, Specimen Volume Forecast By Test Category U.S.A., Total Clinical Chemistry and Immunoassay Test Volume Forecast By Test Category U.S.A., Routine Chemistry Test Volume Forecast By Market Segment U.S.A., TDM Test Volume Forecast By Market Segment U.S.A., Endocrine Function Test Volume Forecast By Market Segment U.S.A., Drugs of Abuse Test Volume Forecast By Market Segment U.S.A., Tumor Markers and Special Chemistry Test Volume Forecast By Market Segment U.S.A., Immunoprotein Test Volume Forecast By Market Segment U.S.A., All Market Segments, Profiles, Panels and Individual Tests Forecast U.S.A., Hospital Laboratories, Profiles, Panels and Individual Tests Forecast U.S.A., Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast U.S.A., Physician Offices/Group Practices, Profiles, Panels and Individual Tests Forecast U.S.A., All Market Segments, Routine Chemistry Test Volume Forecast by Assay U.S.A., Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay U.S.A., Commercial/Private Laboratories, Routine Chemistry Test Volume Forecast by Assay U.S.A., Physician Offices/Group Practices, Routine Chemistry Test Volume ForecastSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
